ArticleEJNMMI physics2026
Enhanced data usability in dynamic
Article in EJNMMI physics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundHead motion during dynamic positron emission tomography (dPET) compromises pharmacokinetic modeling, especially in prolonged acquisitions where motion artifacts invalidate quantitative analysis. Although motion correction methods are well-established for static PET, their application in dynamic imaging remains limited. This study evaluates the efficacy of a data-driven dynamic head motion correction (dHMC) algorithm in preserving the reliability of kinetic parameter, using dynamic 68 Ga-PSMA-11 PET of intracranial tumors as a challenging model due to the tracer’s inability to cross the blood–brain barrier, unlike the diffusely distributed 18F-FDG used in prior studies.
methodsSixteen patients with suspected glioma based on preoperative imaging underwent 40-min dynamic 68 Ga-PSMA-11 PET head scans. Head motion was categorized into minor and high-motion groups based on maximum displacement (> 3 mm) or time-weighted mean displacement (> 2 mm) within the tumor region. The performance of dHMC was evaluated in tumor and reference organs (parotid and lacrimal glands) based on fitting metrics, including the coefficient of determination (R2) and Akaike information criterion (AIC), and quantitative kinetic parameters. Time-activity curves (TACs) and key kinetic parameters (k2 and k3) were generated using an irreversible two-tissue compartment model (2T3k).
resultsdHMC robustly corrected motion-induced inaccuracies across motion levels, enabling analysis in 43.75% of previously non-analyzable cases. The algorithm yielded three major improvements without introducing bias: First, it significantly enhanced pharmacokinetic modeling fidelity, evidenced by smoother TACs, along with increased R2 values of 8.35%, 4.54%, and 30.9% in tumor, parotid, and lacrimal glands, respectively, and reduced AIC values by 6.95%, 5.33%, and 13.32%. Second, it improved the accuracy and homogeneity of k2 and k3 estimates in reference organs, indicated by significantly reduced data dispersion. Third, it brought the quantitative parameters of the parotid gland closer to established reference standards. All improvements were most pronounced in high-motion cases.
conclusionThe dHMC algorithm enhances fitting performance, parametric accuracy, and inter-frame consistency in dynamic 68 Ga-PSMA-11 PET, validating its broad applicability across varying motion scenarios and underscoring the essential role of motion correction in maintaining quantitative accuracy in dPET.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.